Skip to main content
Erschienen in: Rheumatology International 3/2011

01.03.2011 | Original Article

Validation of the World Health Organization disability assessment schedule II (WHODAS-II) in patients with osteoarthritis

verfasst von: Şehim Kutlay, Ayşe A. Küçükdeveci, Atilla H. Elhan, Derya Öztuna, Nihal Koç, Alan Tennant

Erschienen in: Rheumatology International | Ausgabe 3/2011

Einloggen, um Zugang zu erhalten

Abstract

The objective of this study is to test the reliability and validity of WHODAS-II (Turkish version) for the assessment of disability in patients with osteoarthritis. This study is designed as follows: the internal construct validity of WHODAS-II in patients with knee osteoarthritis was assessed by Rasch analysis, and external construct validity by association with the Western Ontario and McMaster Universities Index of Osteoarthritis (WOMAC) and the Nottingham Health Profile (NHP); reliability was tested by internal consistency, intra-class correlation coefficient (ICC) and test–retest ICC. Our study presents the results of 225 outpatients assessed with mean age 58.4 years (SD 11.1) of whom 80.9% were female. Cronbach’s α, ICC, and test–retest ICC values for the six subscales of WHODAS-II varied between 0.71 and 0.94, 0.71 and 0.94, and 0.87 and 0.97, respectively. Rasch analysis of WHODAS-II indicated that after adjustment for local dependency, satisfactory fit was achieved. Two separate ‘activities’ and ‘participation’ components could also be identified. External construct validity of the scale was confirmed with expected correlations with WOMAC and NHP. This study concludes that WHODAS-II provides a reliable and valid health status instrument for measuring disability and components of ‘activities’ and ‘participation’ in patients with osteoarthritis. Thus, it provides the opportunity to model the consequences of disease according to the International Classification of Functioning, Disability and Health framework.
Literatur
1.
Zurück zum Zitat Reginster JY (2002) The prevalence and burden of osteoarthritis. Rheumatol 41(1):3–6CrossRef Reginster JY (2002) The prevalence and burden of osteoarthritis. Rheumatol 41(1):3–6CrossRef
2.
Zurück zum Zitat Botha-Scheepers S, Riyazi N, Kroon HM, Scharloo M, Houwing-Duistermaat JJ, Slagboom E et al (2006) Activity limitations in the lower extremities in patients with osteoarthritis: the modifying effects of illness perceptions and mental health. Osteoarthr Cartil 14(11):1104–1110CrossRefPubMed Botha-Scheepers S, Riyazi N, Kroon HM, Scharloo M, Houwing-Duistermaat JJ, Slagboom E et al (2006) Activity limitations in the lower extremities in patients with osteoarthritis: the modifying effects of illness perceptions and mental health. Osteoarthr Cartil 14(11):1104–1110CrossRefPubMed
3.
Zurück zum Zitat World Health Organization (2001) International classification of functioning, disability and Health (ICF). World Health Organization, Geneva World Health Organization (2001) International classification of functioning, disability and Health (ICF). World Health Organization, Geneva
5.
Zurück zum Zitat Chwastiak LA, Von Korff M (2003) Disability in depression and back pain. Evaluation of WHODAS-II in a primary care setting. J Clin Epidemiol 56(6):507–514CrossRefPubMed Chwastiak LA, Von Korff M (2003) Disability in depression and back pain. Evaluation of WHODAS-II in a primary care setting. J Clin Epidemiol 56(6):507–514CrossRefPubMed
6.
Zurück zum Zitat van Tubergen A, Landewé R, Heuft-Dorenbosch L, Spoorenberg A, van der Heijde D, van der Tempel H (2003) Assessment of disability with the World Health Organisation Disability Assessment Schedule II in patients with ankylosing spondylitis. Ann Rheum Dis 62:140–145CrossRefPubMed van Tubergen A, Landewé R, Heuft-Dorenbosch L, Spoorenberg A, van der Heijde D, van der Tempel H (2003) Assessment of disability with the World Health Organisation Disability Assessment Schedule II in patients with ankylosing spondylitis. Ann Rheum Dis 62:140–145CrossRefPubMed
7.
Zurück zum Zitat Schlote A, Richter M, Wunderlich MT, Poppendick U, Möller C, Wallesch CW (2009) WHODAS-II with people after stroke and their relatives. Disabil Rehabil 31(11):855–864CrossRefPubMed Schlote A, Richter M, Wunderlich MT, Poppendick U, Möller C, Wallesch CW (2009) WHODAS-II with people after stroke and their relatives. Disabil Rehabil 31(11):855–864CrossRefPubMed
8.
Zurück zum Zitat Pösl M, Cieza A, Stucki G (2007) Psychometric properties of the WHODAS-II in rehabilitation patients. Qual Life Res 16(9):1521–1531CrossRefPubMed Pösl M, Cieza A, Stucki G (2007) Psychometric properties of the WHODAS-II in rehabilitation patients. Qual Life Res 16(9):1521–1531CrossRefPubMed
9.
Zurück zum Zitat Ulug B, Ertugrul A, Gogus A, Kabakcı E (2001) Yetiyitimi degerlendirme cizelgesinin (WHODAS-II) sizofreni hastalarında gecerlilik ve güvenilirligi. Turk Psikiyatr Derg 12:121–130 Ulug B, Ertugrul A, Gogus A, Kabakcı E (2001) Yetiyitimi degerlendirme cizelgesinin (WHODAS-II) sizofreni hastalarında gecerlilik ve güvenilirligi. Turk Psikiyatr Derg 12:121–130
10.
Zurück zum Zitat Tüzün EH, Eker L, Aytar A, Daşkapan A, Bayramoğlu M (2005) Acceptability, reliability, validity and responsiveness of the Turkish version of WOMAC osteoarthritis index. Osteoarthr Cartil 13(1):28–33CrossRefPubMed Tüzün EH, Eker L, Aytar A, Daşkapan A, Bayramoğlu M (2005) Acceptability, reliability, validity and responsiveness of the Turkish version of WOMAC osteoarthritis index. Osteoarthr Cartil 13(1):28–33CrossRefPubMed
11.
Zurück zum Zitat European Group for Quality of Life Assessment and Health Measurement (1993) European Guide for Nottingham Health Profile. Brookwood Medical Publications, Surrey European Group for Quality of Life Assessment and Health Measurement (1993) European Guide for Nottingham Health Profile. Brookwood Medical Publications, Surrey
12.
Zurück zum Zitat Kücükdeveci AA, McKenna SP, Kutlay S, Gürsel Y, Whalley D, Arasil T (2000) The development and psychometric assessment of the Turkish version of the Nottingham Health Profile. Int J Rehabil Res 23(1):31–38CrossRefPubMed Kücükdeveci AA, McKenna SP, Kutlay S, Gürsel Y, Whalley D, Arasil T (2000) The development and psychometric assessment of the Turkish version of the Nottingham Health Profile. Int J Rehabil Res 23(1):31–38CrossRefPubMed
13.
Zurück zum Zitat Cronbach LJ (1951) Coefficient alpha and the internal structure of tests. Psychometrika 16:297–334CrossRef Cronbach LJ (1951) Coefficient alpha and the internal structure of tests. Psychometrika 16:297–334CrossRef
14.
Zurück zum Zitat Streiner DL, Norman GR (1995) Health measurement scales. Oxford University Press, Oxford Streiner DL, Norman GR (1995) Health measurement scales. Oxford University Press, Oxford
15.
Zurück zum Zitat Luce RD, Tukey JW (1964) Simultaneous conjoint measurement: a new type of fundamental measurement. J Math Psychol 1:1–27CrossRef Luce RD, Tukey JW (1964) Simultaneous conjoint measurement: a new type of fundamental measurement. J Math Psychol 1:1–27CrossRef
16.
Zurück zum Zitat Perline R, Wright BD, Wainer H (1979) The Rasch model as additive conjoint measurement. Appl Psychol Meas 3:237–256CrossRef Perline R, Wright BD, Wainer H (1979) The Rasch model as additive conjoint measurement. Appl Psychol Meas 3:237–256CrossRef
17.
Zurück zum Zitat Rasch G (1960) Probabilistic models for some intelligence and attainment tests. University of Chicago Press, Chicago Rasch G (1960) Probabilistic models for some intelligence and attainment tests. University of Chicago Press, Chicago
18.
Zurück zum Zitat Andrich D (1978) Rating formulation for ordered response categories. Psychometrika 43:561–573CrossRef Andrich D (1978) Rating formulation for ordered response categories. Psychometrika 43:561–573CrossRef
19.
Zurück zum Zitat Masters GN (1982) A Rasch model for partial credit scoring. Psychometrika 47:149–174CrossRef Masters GN (1982) A Rasch model for partial credit scoring. Psychometrika 47:149–174CrossRef
20.
Zurück zum Zitat Tennant A, Conaghan PG (2007) The Rasch measurement model in rheumatology: what is it and why use it? When should it be applied, and what should one look for in a Rasch paper? Arthritis Rheum 57:1358–1362CrossRefPubMed Tennant A, Conaghan PG (2007) The Rasch measurement model in rheumatology: what is it and why use it? When should it be applied, and what should one look for in a Rasch paper? Arthritis Rheum 57:1358–1362CrossRefPubMed
21.
Zurück zum Zitat Marais I, Andrich D (2008) Formalizing dimension and response violations of local independence in the unidimensional Rasch model. J Appl Meas 9:200–215PubMed Marais I, Andrich D (2008) Formalizing dimension and response violations of local independence in the unidimensional Rasch model. J Appl Meas 9:200–215PubMed
22.
Zurück zum Zitat Wainer H, Kiely GL (1987) Item clusters and computer adaptive testing: a case for testlets. J Educ Meas 24:185–210CrossRef Wainer H, Kiely GL (1987) Item clusters and computer adaptive testing: a case for testlets. J Educ Meas 24:185–210CrossRef
23.
Zurück zum Zitat Smith EV (2002) Detecting and evaluation the impact of multidimensionality using item fit statistics and principal component analysis of residuals. J Appl Meas 3:205–231PubMed Smith EV (2002) Detecting and evaluation the impact of multidimensionality using item fit statistics and principal component analysis of residuals. J Appl Meas 3:205–231PubMed
24.
Zurück zum Zitat Linacre JM (1994) Sample size and item calibration stability. Rasch Meas Trans 7:28 Linacre JM (1994) Sample size and item calibration stability. Rasch Meas Trans 7:28
25.
Zurück zum Zitat Bland JM, Altman DG (1995) Multiple significance tests: the Bonferroni method. BMJ 310:170PubMed Bland JM, Altman DG (1995) Multiple significance tests: the Bonferroni method. BMJ 310:170PubMed
26.
Zurück zum Zitat Andrich D, Lyne A, Sheridan B, Luo G (2003) RUMM 2020. Perth: RUMM Laboratory Duncraig, Western Australia Andrich D, Lyne A, Sheridan B, Luo G (2003) RUMM 2020. Perth: RUMM Laboratory Duncraig, Western Australia
27.
Zurück zum Zitat Weigl M, Cieza A, Harder M, Amann E, Kostanjsek N, Stucki G (2003) Linking osteoarthritis-specific health status measures to the International Classification of Functioning, Disability, and Health (ICF). Osteoarthr Cartil 11(7):519–523CrossRefPubMed Weigl M, Cieza A, Harder M, Amann E, Kostanjsek N, Stucki G (2003) Linking osteoarthritis-specific health status measures to the International Classification of Functioning, Disability, and Health (ICF). Osteoarthr Cartil 11(7):519–523CrossRefPubMed
28.
Zurück zum Zitat Dreinhofer K, Stuki G, Ewert T, Huber E, Ebenbichler G, Gutenbrunner C, Kostanjsek N, Cieza A (2004) ICF core sets for osteoarthritis. J Rehabil Med (Suppl 44):75–80 Dreinhofer K, Stuki G, Ewert T, Huber E, Ebenbichler G, Gutenbrunner C, Kostanjsek N, Cieza A (2004) ICF core sets for osteoarthritis. J Rehabil Med (Suppl 44):75–80
Metadaten
Titel
Validation of the World Health Organization disability assessment schedule II (WHODAS-II) in patients with osteoarthritis
verfasst von
Şehim Kutlay
Ayşe A. Küçükdeveci
Atilla H. Elhan
Derya Öztuna
Nihal Koç
Alan Tennant
Publikationsdatum
01.03.2011
Verlag
Springer-Verlag
Erschienen in
Rheumatology International / Ausgabe 3/2011
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-009-1306-8

Weitere Artikel der Ausgabe 3/2011

Rheumatology International 3/2011 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.